找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Chondrosarcoma; Biology and Clinical Francis J. Hornicek Book 2021 Springer Nature Switzerland AG 2021 Cartilage.Chondrosarcoma.Extraskelet

[復(fù)制鏈接]
樓主: VIRAL
11#
發(fā)表于 2025-3-23 09:56:34 | 只看該作者
12#
發(fā)表于 2025-3-23 17:01:48 | 只看該作者
The Future of Chondrosarcoma Research and Treatmentrs, with conventional chondrosarcomas having a notably bleak prognosis due to their resistance to available therapies. Recent technologies such as next-generation sequencing (NGS) have captured the genomic complexity of chondrosarcoma biology, including their variations in DNA mutational profiles, e
13#
發(fā)表于 2025-3-23 18:23:12 | 只看該作者
14#
發(fā)表于 2025-3-24 00:51:35 | 只看該作者
Radiation Therapy for Chondrosarcomashould be considered for particle-based therapies (proton or carbon ion) when possible. Photon-based therapies should be delivered using advanced image guidance and intensity-modulated radiotherapy. For smaller tumors in the skull base, stereotactic radiosurgery should be considered. Radiation thera
15#
發(fā)表于 2025-3-24 05:29:44 | 只看該作者
16#
發(fā)表于 2025-3-24 07:00:51 | 只看該作者
amines the future of chondrosarcoma management and development of novel adjuvant therapies, as well as the relationship of this disease to similar types (e.g., chordoma)...?Bringing together the most up-to-date978-3-030-74571-4978-3-030-74572-1
17#
發(fā)表于 2025-3-24 12:41:29 | 只看該作者
https://doi.org/10.1007/978-3-322-96454-0 and radiation, although rare histologies and inoperable sites will still be treated with these modalities. Notable controversies persist in the surgical treatment of low-grade chondrosarcoma, in the feasibility of limb salvage in the setting of pathologic fracture, and in the management of chondros
18#
發(fā)表于 2025-3-24 14:51:03 | 只看該作者
19#
發(fā)表于 2025-3-24 19:00:22 | 只看該作者
Rechnungswesen, Controlling, Bankrechnenperately needed, and future clinical management will likely be informed by an improved understanding of subtype-specific pathways to aid in combination therapy selection. In this chapter, we discuss the future of chondrosarcoma research and summarize ongoing clinical trials evaluating novel approach
20#
發(fā)表于 2025-3-24 23:23:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 22:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
苏州市| 寿光市| 沧州市| 兴业县| 科尔| 如皋市| 大冶市| 安远县| 汾阳市| 岱山县| 滨州市| 嘉禾县| 乐业县| 石渠县| 合肥市| 清流县| 大埔区| 凤阳县| 郓城县| 芜湖市| 靖州| 茶陵县| 阿城市| 邵阳市| 临泽县| 新源县| 德格县| 洞口县| 奈曼旗| 双柏县| 博罗县| 阿拉善右旗| 湖南省| 陈巴尔虎旗| 含山县| 钦州市| 白水县| 睢宁县| 灌云县| 阜宁县| 荣昌县|